FR3099698B1 - Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme et à retrouver la forme - Google Patents

Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme et à retrouver la forme Download PDF

Info

Publication number
FR3099698B1
FR3099698B1 FR1908999A FR1908999A FR3099698B1 FR 3099698 B1 FR3099698 B1 FR 3099698B1 FR 1908999 A FR1908999 A FR 1908999A FR 1908999 A FR1908999 A FR 1908999A FR 3099698 B1 FR3099698 B1 FR 3099698B1
Authority
FR
France
Prior art keywords
combination product
shape
help maintain
natural defenses
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1908999A
Other languages
English (en)
Other versions
FR3099698A1 (fr
Inventor
Marilyn Gentilhomme
France Viroux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Urgo Recherche Innovation et Developpement
Original Assignee
Urgo Recherche Innovation et Developpement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urgo Recherche Innovation et Developpement filed Critical Urgo Recherche Innovation et Developpement
Priority to FR1908999A priority Critical patent/FR3099698B1/fr
Priority to PCT/EP2020/071443 priority patent/WO2021023600A1/fr
Publication of FR3099698A1 publication Critical patent/FR3099698A1/fr
Application granted granted Critical
Publication of FR3099698B1 publication Critical patent/FR3099698B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Animal Husbandry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La présente invention a pour objet un produit de combinaison comprenant à titre de substances actives, au moins de la gelée royale, de la spiruline, de la vitamine C, de la vitamine D3, des vitamines du groupe B ainsi qu’au moins une souche bactérienne pour aider au maintien des défenses naturelles de l’organisme et à retrouver la forme. L'invention concerne enfin l'utilisation d'un produit de combinaison tel que précédemment défini pour la prévention et/ou le traitement des pathologies infectieuses, qu’elles soient d’origine virale ou bactérienne.
FR1908999A 2019-08-06 2019-08-06 Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme et à retrouver la forme Active FR3099698B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1908999A FR3099698B1 (fr) 2019-08-06 2019-08-06 Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme et à retrouver la forme
PCT/EP2020/071443 WO2021023600A1 (fr) 2019-08-06 2020-07-29 Produit de combinaison pour aider au maintien des défenses naturelles de l'organisme et à retrouver la forme

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1908999A FR3099698B1 (fr) 2019-08-06 2019-08-06 Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme et à retrouver la forme
FR1908999 2019-08-06

Publications (2)

Publication Number Publication Date
FR3099698A1 FR3099698A1 (fr) 2021-02-12
FR3099698B1 true FR3099698B1 (fr) 2022-07-08

Family

ID=69104574

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1908999A Active FR3099698B1 (fr) 2019-08-06 2019-08-06 Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme et à retrouver la forme

Country Status (2)

Country Link
FR (1) FR3099698B1 (fr)
WO (1) WO2021023600A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3121351B1 (fr) * 2021-03-30 2024-03-08 Axeen Pharma Composition à base de spiruline et ses utilisations pour le renforcement de l’immunité

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
IT1402348B1 (it) 2010-09-17 2013-08-30 Biofarma S P A Dispositivo di chisura per un flacone e flacone comprendente tale dispositivo di chiusura
US8747915B1 (en) * 2011-09-14 2014-06-10 Vincent C. Giampapa Dietary supplement system for multifunctional anti-aging management and method of use

Also Published As

Publication number Publication date
FR3099698A1 (fr) 2021-02-12
WO2021023600A1 (fr) 2021-02-11

Similar Documents

Publication Publication Date Title
Moller et al. Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol
Tavassoli-Hojjati et al. Pomegranate juice (Punica granatum): a new storage medium for avulsed teeth
Rajaraman et al. Effect of edentulism on general health and quality of life
FR3099698B1 (fr) Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme et à retrouver la forme
MA30035B1 (fr) Utilisation d'un extrait insaponifiable de pulpe vegetale dans le traitement du vieillssement cutane
PT1796702E (pt) Utilização de óleo de lavanda para profilaxia e tratamento de distúrbios de somatização e da doença de stress pós-traumático
FR3097743B1 (fr) Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme
FR3097744B1 (fr) Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme
HUP0102159A2 (hu) Készítmény savtúltengés kezelésére
EA202190921A1 (ru) Кремниевые кислоты для применения в лечении периодонтита
Thomasson Physicians' social responsibility.
Cho et al. Infective endocarditis due to multiple species of anaerobes following tricuspid valve replacement
MD3906G2 (ro) Metodă de tratament al enurezisului nevrotic la copii
MX2015004577A (es) Suplemento nutricional para pacientes con enfermedades reumaticas.
FR2647784A1 (fr) Association de vitamine a a dose physiologique et de differents principes actifs ayant une activite therapeutique
JP7312286B2 (ja) うつ病を予防または治療するための安息香酸またはその塩および誘導体
Chierakul Update on treatment of melioidosis
Shaikh et al. A Randomized Double Blind Controlled Trial of Ringers Lactate Versus Normal Saline Among Pediatric Patients with Acute Severe Diarrhea
FR3129085B1 (fr) Composition pour l’amélioration du bien-être cutané
Borràs et al. Medicinal Use of Cannabis in Spain.
Rowland et al. Broader definitions of clinical effectiveness are needed.
Devi A Correlational Study to Assess the Knowledge on Nutrition of Under Five Children among the Migrating Mothers and Prevalence of Nutritional Problems among Their Children in Selected Rural Community, Thiruvallur District, Tamil Nadu.
Davis et al. 182 Immodulatory medication use for youth with newly-diagnosed systemic lupus erythematosus
Fran et al. Assessment of the Nutritional Status of Children on Arvs in the Prevention of Mother Transmission (PMTCT) Child Centers in the Ruashi Health Zone in Lubumbashi in Dr Congo
Aleksandrovskiĭ et al. Efficacy and tolerability of coaxil (tianeptine) in the therapy of posttraumatic stress disorder

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20210212

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5